CIK 0001672619
- Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811523849
- Phone
- +1 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,585,364
- in 5 filings, $979K under 10b5-1 plans
Net −$1,585,364. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-22 | GRAY MICHAEL CFO & COO | Sale | −9,856 | $4.67 | $46K | 27,610 |
| 2023-01-30 | GRAY MICHAEL CFO & COO | Sale | −3,596 | $3.92 | $14K | 37,466 |
| 2022-01-28 | GRAY MICHAEL CFO & COO | Grant or award | +39,350 | 42,312 | ||
| 2022-01-28 | GRAY MICHAEL CFO & COO | Grant or award · Stock Option (right to buy) | +39,350 | 39,350 | ||
| 2021-01-26 | GRAY MICHAEL CFO & COO | Grant or award · Stock Option (right to buy) | +60,800 | 60,800 | ||
| 2020-12-11 | GRAY MICHAEL CFO & COO | Exercise or conversion | +1,250 | $4.92 | $6K | 1,250 |
| 2020-12-11 | GRAY MICHAEL CFO & COO | Sale | −1,250 | $25.00 | $31K | 0 |
| 2020-12-11 | GRAY MICHAEL CFO & COO | Exercise or conversion · Stock Option (Right to Buy) | −1,250 | 223,059 |
Page 1 of 1 · 8 trades